Geron | GERN - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Amgen USD 5.87B 1.02B 2026-03
Bio Techne USD 222.15M 13.86M 2026-06
Cassava Sciences USD -3.96M 1.16M 2025-09
Cytokinetics USD 23.03M 3.84M 2026-06
Exelixis USD 608.03M 17.17M 2026-06
Genmab DKK 1.07B 240M 2026-06
Geron USD 50.14M 3.44M 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
Incyte USD 1.57B 400.89M 2026-06
MacroGenics USD 11.24M 19.87M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Novavax USD 125.04M 76.09M 2025-12